Schuler A, Huser J, Schmid S, Schar S, et al. Patterns of progression on first line osimertinib in patients with EGFR mutation-positive advanced non-small cell lung cancer (NSCLC): A Swiss cohort study. Lung Cancer 2023;187:107427.
PMID: 38043395